About Cyclo Therapeutics, Inc. 
Cyclo Therapeutics, Inc.
Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 3 Schemes (2.78%)
Foreign Institutions
Held by 7 Foreign Institutions (0.05%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2024)
Net Profit:
-4 Million
Biotechnology
USD 21 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.85
159.14%
-1.40






